Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@houndcl Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::475382695.png) @houndcl L

L posts on X about $abvx, $pali, why is, $ptgx the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::475382695/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::475382695/c:line/m:interactions.svg)

- X Week XXXXXX -XX%
- X Month XXXXXXX +150%
- X Months XXXXXXX +298%
- X Year XXXXXXX +2,984%

### Mentions: XX [#](/creator/twitter::475382695/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::475382695/c:line/m:posts_active.svg)

- X Week XX +4.90%
- X Month XX +56%
- X Months XXX +71%
- X Year XXX +649%

### Followers: XXXXX [#](/creator/twitter::475382695/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::475382695/c:line/m:followers.svg)

- X Week XXXXX +0.98%
- X Month XXXXX +13%
- X Months XXXXX +76%
- X Year XXXXX +131%

### CreatorRank: XXXXXXX [#](/creator/twitter::475382695/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::475382695/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::475382695/influence)
---

**Social category influence**
[technology brands](/list/technology-brands)  XXXX%

**Social topic influence**
[$abvx](/topic/$abvx) #6, [$pali](/topic/$pali) #5, [why is](/topic/why-is) 0.87%, [$ptgx](/topic/$ptgx) 0.44%, [this shit](/topic/this-shit) 0.44%, [save the](/topic/save-the) 0.44%, [sec](/topic/sec) 0.44%, [sap](/topic/sap) 0.44%, [its just](/topic/its-just) 0.44%, [all the](/topic/all-the) XXXX%

**Top accounts mentioned or mentioned by**
[@bioinvestor24](/creator/undefined) [@notgenentech](/creator/undefined) [@aaronrosenblum5](/creator/undefined) [@plainyogurt21](/creator/undefined) [@avidresearch](/creator/undefined) [@amaymd](/creator/undefined) [@banana_oncology](/creator/undefined) [@financebully](/creator/undefined) [@john_hersc79276](/creator/undefined) [@badinvestor99](/creator/undefined) [@bananaoncology](/creator/undefined) [@snupsnus](/creator/undefined) [@jeremyj0916](/creator/undefined) [@duedoctor](/creator/undefined) [@smiuffy](/creator/undefined) [@hothomaswphelps](/creator/undefined) [@jfais20](/creator/undefined) [@applehelix](/creator/undefined) [@snakinglol](/creator/undefined) [@sanctuary_bio](/creator/undefined)

**Top assets mentioned**
[Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [Marblex (MBX)](/topic/$mbx)
### Top Social Posts [#](/creator/twitter::475382695/posts)
---
Top posts by engagements in the last XX hours

"JNJ is in talks with PTGX regarding how to manufacture X tons of this shit annually"  
[X Link](https://x.com/houndcl/status/1976670518628737433) [@houndcl](/creator/x/houndcl) 2025-10-10T15:25Z 3002 followers, 17.6K engagements


"Yesterday during Akeso's conference call Person A messaged person B: why everyone is silent on the statistics Person B: You don't want to be hated do you Lol. Can't post the screenshot but trust me. True story"  
[X Link](https://x.com/houndcl/status/1960862344952864860) [@houndcl](/creator/x/houndcl) 2025-08-28T00:29Z 3002 followers, 6786 engagements


"Point72 filed 13g to own XXX% of $PALI"  
[X Link](https://x.com/houndcl/status/1975685432110354582) [@houndcl](/creator/x/houndcl) 2025-10-07T22:11Z 3002 followers, 7384 engagements


"Wear a black hat for a sec: $PALI is now a 460M biotech with a phase X asset. Chasers pls know your risk"  
[X Link](https://x.com/houndcl/status/1976024340245459388) [@houndcl](/creator/x/houndcl) 2025-10-08T20:38Z 3002 followers, 19K engagements


"@AppleHelix @bigpharmaguy @TCellEngager @aditharun_ @sharkbiotech I'm not drawing a line and saying the result is nonsense. We need to access the SAP and different imputation methods to better understand if the efficacy is real as well as the risk benefit. It's just the analogy of BBIO-acoramidis to PRAX-ulixacaltamide that is not accurate"  
[X Link](https://x.com/houndcl/status/1978937884133429755) [@houndcl](/creator/x/houndcl) 2025-10-16T21:35Z 3002 followers, XXX engagements


"@realchinesespy Same. My biggest loss of this year๐Ÿ˜‚ cleared all the gains from ATYR short"  
[X Link](https://x.com/houndcl/status/1978237182260240825) [@houndcl](/creator/x/houndcl) 2025-10-14T23:11Z 2994 followers, XXX engagements


"Why is Genmab even able to buy Merus"  
[X Link](https://x.com/houndcl/status/1972426400255844789) [@houndcl](/creator/x/houndcl) 2025-09-28T22:21Z 2999 followers, 6354 engagements


"8.0 billion all cash. A bold bet from $gmab"  
[X Link](https://x.com/houndcl/status/1972533888984682537) [@houndcl](/creator/x/houndcl) 2025-09-29T05:28Z 3000 followers, 3805 engagements


"$PALI Mufemilast an PDE4 inhibitor demonstrated XX% and XX% pbo-adj remission in the induction phase ๐Ÿ”ฅ๐Ÿ”ฅ"  
[X Link](https://x.com/houndcl/status/1975056251525689382) [@houndcl](/creator/x/houndcl) 2025-10-06T04:31Z 3000 followers, 59.4K engagements


"$ABVX new data on patients with prior inadequate response to advanced therapies (AT-IR). $XXX go go go"  
[X Link](https://x.com/houndcl/status/1975065962937516472) [@houndcl](/creator/x/houndcl) 2025-10-06T05:09Z 2999 followers, 8984 engagements


"@_financeken @seedy19tron The valuation of such "promising" early asset is that clear nowadays. No longer 2016 era where MORF can sit at 1.4B. Maybe biotech market will be bullish again. Maybe not. ABVX was valued at 500M before July. It IS promising but after FSCD it will face a catalyst desert"  
[X Link](https://x.com/houndcl/status/1976262443786699018) [@houndcl](/creator/x/houndcl) 2025-10-09T12:24Z 2999 followers, XXX engagements


"$MBX round trip post MBX 2109 phase X readout. Now XX% below the offering pricing in this biotech bull market"  
[X Link](https://x.com/houndcl/status/1978235478584258907) [@houndcl](/creator/x/houndcl) 2025-10-14T23:04Z 2999 followers, 3472 engagements


"@seedy19tron BP will view these early early assets more cautiously after $morf failed"  
[X Link](https://x.com/houndcl/status/1976257384562733300) [@houndcl](/creator/x/houndcl) 2025-10-09T12:04Z 3002 followers, 1646 engagements


"$ABVX ABX464 story"  
[X Link](https://x.com/houndcl/status/1976333668403781933) [@houndcl](/creator/x/houndcl) 2025-10-09T17:07Z 3002 followers, 6178 engagements


"$ABVX 7.5B MC reached"  
[X Link](https://x.com/houndcl/status/1978151189955989627) [@houndcl](/creator/x/houndcl) 2025-10-14T17:29Z 3002 followers, 5532 engagements


"Who wins the CNPV of ketamine It only costs $200-300 to buy 1kg ketamine from other countries"  
[X Link](https://x.com/houndcl/status/1978941621527023661) [@houndcl](/creator/x/houndcl) 2025-10-16T21:50Z 3002 followers, 3177 engagements


"@john_hersc79276 @jfais20 Ulixacaltamide is a small molecule. I don't think it has ADA. The waning efficacy is probably due to drop out"  
[X Link](https://x.com/houndcl/status/1979208503228273081) [@houndcl](/creator/x/houndcl) 2025-10-17T15:30Z 3002 followers, XXX engagements


"@Craigster771 @john_hersc79276 Cobenfy review record. FDA will definitely check if the conclusion from mITT is fragile"  
[X Link](https://x.com/houndcl/status/1979226603722010954) [@houndcl](/creator/x/houndcl) 2025-10-17T16:42Z 3002 followers, XXX engagements


"@Craigster771 @john_hersc79276 Xcopri has XX% discontinuation in the highest dose group. That's fine. Primary is still on ITT and the N in the mITT population are still balanced. In Prax's case I don't think FDA will ignore the XX% patients with missing post-baseline measurement while only XXX% in pbo"  
[X Link](https://x.com/houndcl/status/1979229193566326784) [@houndcl](/creator/x/houndcl) 2025-10-17T16:53Z 3002 followers, XXX engagements


"Maybe the next $ABVX. is $ABVX -- Sheep"  
[X Link](https://x.com/houndcl/status/1979233059217248689) [@houndcl](/creator/x/houndcl) 2025-10-17T17:08Z 3002 followers, 4225 engagements


"Stop comparing PFS between PIK3CA mutant and WT in HR+ HER2- breast cancer"  
[X Link](https://x.com/houndcl/status/1979566829648633870) [@houndcl](/creator/x/houndcl) 2025-10-18T15:14Z 3002 followers, 1810 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@houndcl Avatar @houndcl L

L posts on X about $abvx, $pali, why is, $ptgx the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

  • X Week XXXXXX -XX%
  • X Month XXXXXXX +150%
  • X Months XXXXXXX +298%
  • X Year XXXXXXX +2,984%

Mentions: XX #

Mentions Line Chart

  • X Week XX +4.90%
  • X Month XX +56%
  • X Months XXX +71%
  • X Year XXX +649%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.98%
  • X Month XXXXX +13%
  • X Months XXXXX +76%
  • X Year XXXXX +131%

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence technology brands XXXX%

Social topic influence $abvx #6, $pali #5, why is 0.87%, $ptgx 0.44%, this shit 0.44%, save the 0.44%, sec 0.44%, sap 0.44%, its just 0.44%, all the XXXX%

Top accounts mentioned or mentioned by @bioinvestor24 @notgenentech @aaronrosenblum5 @plainyogurt21 @avidresearch @amaymd @banana_oncology @financebully @john_hersc79276 @badinvestor99 @bananaoncology @snupsnus @jeremyj0916 @duedoctor @smiuffy @hothomaswphelps @jfais20 @applehelix @snakinglol @sanctuary_bio

Top assets mentioned Protagonist Therapeutics, Inc (PTGX) Marblex (MBX)

Top Social Posts #


Top posts by engagements in the last XX hours

"JNJ is in talks with PTGX regarding how to manufacture X tons of this shit annually"
X Link @houndcl 2025-10-10T15:25Z 3002 followers, 17.6K engagements

"Yesterday during Akeso's conference call Person A messaged person B: why everyone is silent on the statistics Person B: You don't want to be hated do you Lol. Can't post the screenshot but trust me. True story"
X Link @houndcl 2025-08-28T00:29Z 3002 followers, 6786 engagements

"Point72 filed 13g to own XXX% of $PALI"
X Link @houndcl 2025-10-07T22:11Z 3002 followers, 7384 engagements

"Wear a black hat for a sec: $PALI is now a 460M biotech with a phase X asset. Chasers pls know your risk"
X Link @houndcl 2025-10-08T20:38Z 3002 followers, 19K engagements

"@AppleHelix @bigpharmaguy @TCellEngager @aditharun_ @sharkbiotech I'm not drawing a line and saying the result is nonsense. We need to access the SAP and different imputation methods to better understand if the efficacy is real as well as the risk benefit. It's just the analogy of BBIO-acoramidis to PRAX-ulixacaltamide that is not accurate"
X Link @houndcl 2025-10-16T21:35Z 3002 followers, XXX engagements

"@realchinesespy Same. My biggest loss of this year๐Ÿ˜‚ cleared all the gains from ATYR short"
X Link @houndcl 2025-10-14T23:11Z 2994 followers, XXX engagements

"Why is Genmab even able to buy Merus"
X Link @houndcl 2025-09-28T22:21Z 2999 followers, 6354 engagements

"8.0 billion all cash. A bold bet from $gmab"
X Link @houndcl 2025-09-29T05:28Z 3000 followers, 3805 engagements

"$PALI Mufemilast an PDE4 inhibitor demonstrated XX% and XX% pbo-adj remission in the induction phase ๐Ÿ”ฅ๐Ÿ”ฅ"
X Link @houndcl 2025-10-06T04:31Z 3000 followers, 59.4K engagements

"$ABVX new data on patients with prior inadequate response to advanced therapies (AT-IR). $XXX go go go"
X Link @houndcl 2025-10-06T05:09Z 2999 followers, 8984 engagements

"@_financeken @seedy19tron The valuation of such "promising" early asset is that clear nowadays. No longer 2016 era where MORF can sit at 1.4B. Maybe biotech market will be bullish again. Maybe not. ABVX was valued at 500M before July. It IS promising but after FSCD it will face a catalyst desert"
X Link @houndcl 2025-10-09T12:24Z 2999 followers, XXX engagements

"$MBX round trip post MBX 2109 phase X readout. Now XX% below the offering pricing in this biotech bull market"
X Link @houndcl 2025-10-14T23:04Z 2999 followers, 3472 engagements

"@seedy19tron BP will view these early early assets more cautiously after $morf failed"
X Link @houndcl 2025-10-09T12:04Z 3002 followers, 1646 engagements

"$ABVX ABX464 story"
X Link @houndcl 2025-10-09T17:07Z 3002 followers, 6178 engagements

"$ABVX 7.5B MC reached"
X Link @houndcl 2025-10-14T17:29Z 3002 followers, 5532 engagements

"Who wins the CNPV of ketamine It only costs $200-300 to buy 1kg ketamine from other countries"
X Link @houndcl 2025-10-16T21:50Z 3002 followers, 3177 engagements

"@john_hersc79276 @jfais20 Ulixacaltamide is a small molecule. I don't think it has ADA. The waning efficacy is probably due to drop out"
X Link @houndcl 2025-10-17T15:30Z 3002 followers, XXX engagements

"@Craigster771 @john_hersc79276 Cobenfy review record. FDA will definitely check if the conclusion from mITT is fragile"
X Link @houndcl 2025-10-17T16:42Z 3002 followers, XXX engagements

"@Craigster771 @john_hersc79276 Xcopri has XX% discontinuation in the highest dose group. That's fine. Primary is still on ITT and the N in the mITT population are still balanced. In Prax's case I don't think FDA will ignore the XX% patients with missing post-baseline measurement while only XXX% in pbo"
X Link @houndcl 2025-10-17T16:53Z 3002 followers, XXX engagements

"Maybe the next $ABVX. is $ABVX -- Sheep"
X Link @houndcl 2025-10-17T17:08Z 3002 followers, 4225 engagements

"Stop comparing PFS between PIK3CA mutant and WT in HR+ HER2- breast cancer"
X Link @houndcl 2025-10-18T15:14Z 3002 followers, 1810 engagements

@houndcl
/creator/twitter::houndcl